dacarbazine has been researched along with Granulocytic Leukemia, Chronic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldini, L; F, FG; Ferrario, A; Goldaniga, M; Olivero, B; Radaelli, F; Rossi, F | 1 |
| Ahmed, T; Baskind, P; Liu, D; Loughran, T; Seiter, K; Siddiqui, A | 1 |
| Chiusolo, P; De Matteis, S; De Vita, S; Fiorini, A; Laurenti, L; Leone, G; Reddiconto, G; Sica, S | 1 |
| Jean-Claude, BJ; Katsoulas, A; McNamee, JP; Rachid, Z; Williams, C | 1 |
| Deans, B; Tisdale, MJ | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 1 |
| Catapano, CV; D'Incalci, M; Erba, E; Filippeschi, S; Zucchetti, M | 1 |
1 trial(s) available for dacarbazine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Phase I study of temozolomide in relapsed/refractory acute leukemia.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide; Treatment Outcome | 2002 |
6 other study(ies) available for dacarbazine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Recurrence; Vinblastine | 2010 |
Secondary Ph+ acute lymphoblastic leukemia after temozolomide.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Central Nervous System Neoplasms; Dacarbazine; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Temozolomide | 2005 |
Combi-targeting concept: an optimized single-molecule dual-targeting model for the treatment of chronic myelogenous leukemia.
Topics: Antineoplastic Agents; Cell Cycle; Cell Proliferation; Dacarbazine; DNA Damage; DNA-Binding Proteins; Genes, abl; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Biological; Molecular Chaperones; Oncogene Proteins; RNA-Binding Proteins; Temozolomide; Tumor Suppressor Protein p53 | 2008 |
Antitumour imidazotetrazines XXVIII 3-methyladenine DNA glycosylase activity in cell lines sensitive and resistant to temozolomide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Burkitt Lymphoma; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dacarbazine; DNA Glycosylases; DNA Repair; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Mice; N-Glycosyl Hydrolases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sulfuric Acid Esters; Temozolomide | 1992 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomycin; Body Height; Body Weight; Child; Child Development; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulins; Intelligence; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Sex Characteristics; Vinblastine; Vincristine | 1991 |
Temozolomide induced differentiation of K562 leukemia cells is not mediated by gene hypomethylation.
Topics: Blotting, Northern; Cell Cycle; Cell Differentiation; Dacarbazine; DNA Damage; DNA, Neoplasm; Flow Cytometry; Genes, ras; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methylation; Proto-Oncogenes; Temozolomide; Tumor Cells, Cultured | 1989 |